Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide. The report provides a detailed overview of drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the plasma therapy industry, along with estimates and forecast of the revenue and market share analysis.

The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0%.

Get More Crucial Insights: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333

Application of Plasma Therapy Market:

On the basis of application, the plasma therapy industry is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further categorized into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is classified into androgenic alopecia and plastic surgery. Among all applications, the dermatology segment is expected to grow at a high CAGR from 2016 to 2021, owing to increase in the adoption of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia.

Pure PRP Plasma Therapy:

The pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2016. This segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of the pure PRP segment can be attributed to its high success rate and its antimicrobial effects.

Autologous Plasma Therapy:

The autologous segment is estimated to account for the largest share of the global plasma therapy market in 2016, owing to its safety and effective results. Prevalence of orthopedic disorders such as arthritis and tendinitis has propelled the demand for advanced treatment options. This has further contributed to the growth of the plasma therapy industry.

Plasma Therapy Market Growth in Hospitals and Clinics:

With respect to end user, the plasma therapy industry is segmented into hospitals & clinics and research institutes. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy in 2016. Rise in healthcare spending has resulted in the increasing use of platelet-rich plasma therapy (PRP) in hospitals & clinics.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333

Geographical Growth Analysis of Plasma Therapy Market:

The global plasma therapy industry is segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). North America is estimated to account for the largest share of the global plasma therapy industry in 2016. This large share is mainly attributed to the increase in aging population and initiatives undertaken by the government to support developments in the field of plasma therapy.

Key Market Players:

Key players in the global plasma therapy industry include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB S.A. (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland). 

The global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions.

What are the Global Growth Factors?

Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardiac muscle injury, and dental applications.

What is the future analysis of Plasma Therapy Market?

The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333

Global Market Segmentation:

The global market is segmented on the basis of type, source, application, end user, and region.

On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). The pure PRP segment is estimated to account for the largest share of the global market in 2016. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market.

On the basis of source, the market is segmented into autologous and allogenic. The autologous segment is estimated to account for the largest share of the global market in 2016. Awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues are driving the growth of the autologous source segment of the market.

Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology segment is expected to grow at the highest CAGR from 2016 to 2021, owing to the increasing number of dermatological disorders.

On the basis of end user, the market is classified into hospitals & clinics and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market in 2016. This large share is mainly attributed to rise in healthcare expenditure and increase in the use of PRP products in hospitals.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186196333

Geographical Analysis:

Geographically, the market is led by North America, followed by Europe, Asia-Pacific, and rest of the world (RoW). Growth in the global market is primarily driven by the increase in aging population and rise in the number of orthopedic disorders.

Target Audience of Plasma Therapy Market:

1. Platelet-rich Plasma (PRP) Manufacturers and Suppliers
2. Academic Research Institutes
3. Hospitals & Clinics
4. Research & Development (R&D) Companies
5. Business Research & Consulting Service Providers
6. Medical Research Laboratories
7. Academic Medical Centers & Universities

Key Players:

Major players operating in Plasma Therapy Market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland).